We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT01857193
Brief Title: Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer

First Submitted : May 16, 2013
First Submitted that Met QC Criteria : May 16, 2013
First Posted : May 20, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : April 8, 2021
Last Update Posted : April 13, 2021